Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma: a Randomized, Phase III, Non-inferiority studY (PRIORITY Study)

NCT07256158 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT07256158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07256158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma: a Randomized, Phase III, Non-inferiority studY (PRIORITY Study)
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Phase 3
Overall status
Recruiting
Start date
July 10, 2026
Completion date
August 31, 2033
Enrollment
518 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma